In a rat model of global stroke, a pinocembrin treatment administered daily for 7 days before a stroke decreased the infarct size and NF-κB, TNF-α, and IL-6 in the hippocampal tissue [128]. This evidence concerns the gene NFKB1 and stroke disorder.